NCT02178410View on ClinicalTrials.gov

VITAL Rhythm Study

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

25,119

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Cardiovascular Disease
Interventions
DIETARY_SUPPLEMENT

Vitamin D3

Vitamin D3 (cholecalciferol), 2000 IU per day.

DRUG

Omega-3 fatty acids (fish oil)

Omacor, 1 capsule per day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \[EPA\] and 375 mg of docosahexaenoic acid \[DHA\]).

DIETARY_SUPPLEMENT

Fish oil placebo

Fish oil placebo

DIETARY_SUPPLEMENT

Vitamin D3 placebo

Vitamin D3 placebo

Trial Locations (1)

02215

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Cedars-Sinai Medical Center

OTHER

lead

Brigham and Women's Hospital

OTHER